Literature DB >> 3417234

Hepatitis D virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis D virus infection.

M Buti1, R Esteban, M Roggendorf, J Fernandez, R Jardi, R Rashofer, H Allende, J Genesca, J I Esteban, J Guardia.   

Abstract

To evaluate the profile of hepatitis D virus replication and the corresponding immunoresponse after acute hepatitis D virus infection, sera from 50 patients with acute hepatitis D (36 with acute hepatitis B virus-hepatitis D virus coinfection and 14 HBsAg carriers with hepatitis D virus superinfection) were investigated for the presence of hepatitis D virus RNA and other serological hepatitis D virus markers. During the first week after onset of symptoms, hepatitis D virus RNA was detected by spot hybridization with a similar frequency among patients with coinfection (64%) and those with superinfection (71%). The presence of hepatitis D virus RNA in the first serum sample correlated with that of circulating hepatitis D antigen in both groups of patients. The presence of hepatitis D virus RNA was transient and its clearance paralleled that of serum hepatitis D antigen among patients with coinfection, so that 1 month after the onset of symptoms serum hepatitis D virus RNA was no longer detectable in any of these patients. Conversely, serum hepatitis D virus RNA was still present in 78% of those with superinfection, all of whom developed chronic liver disease, thus suggesting that the persistence of hepatitis D virus RNA in the serum for more than 4 weeks might indicate progression to chronicity. In nine of the 14 patients (64%) with hepatitis D virus superinfection progressing to chronicity, hepatitis D virus RNA was persistently detected throughout the follow-up, whereas in five patients it was detected occasionally. In four superinfected patients hepatitis D virus RNA and hepatitis B virus DNA were detected simultaneously in serial samples, thus suggesting that, at least during early stages of chronic hepatitis D virus infection, both viruses may replicate at the same time.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3417234     DOI: 10.1002/hep.1840080526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

Review 1.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

2.  Immune response to synthetic peptides of hepatitis delta antigen.

Authors:  F Poisson; F Baillou; F Dubois; B Janvier; P Roingeard; A Goudeau
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Correlation between hepatitis B viremia and the clinical and histological activity of chronic delta hepatitis.

Authors:  J L Lozano; J Crespo; F de la Cruz; F Casafont; M J Lopez-Arias; L Martín-Ramos; F Pons-Romero
Journal:  Med Microbiol Immunol       Date:  1994-07       Impact factor: 3.402

Review 4.  Delta hepatitis: molecular biology and clinical and epidemiological features.

Authors:  L B Polish; M Gallagher; H A Fields; S C Hadler
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

Review 5.  HDV Pathogenesis: Unravelling Ariadne's Thread.

Authors:  Eirini D Tseligka; Sophie Clément; Francesco Negro
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

6.  Prevalence and risk factors of Hepatitis D virus antibody among asymptomatic carriers of Hepatitis B virus: a community survey.

Authors:  Uchenna C Okonkwo; Henry C Okpara; Kenneth Inaku; Tony M Aluka; Evaristus S Chukwudike; Yeonun Ogarekpe; Emin J Emin; Osim Hodo; Akaninyene A Otu
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

Review 7.  Hepatitis delta: virological and clinical aspects.

Authors:  Luan Felipo Botelho-Souza; Mariana Pinheiro Alves Vasconcelos; Alcione de Oliveira Dos Santos; Juan Miguel Villalobos Salcedo; Deusilene Souza Vieira
Journal:  Virol J       Date:  2017-09-13       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.